FRMPD4
protein-codingFERM and PDZ domain containing 4, the group of PDZ domain containing|FERM domain containing
Gene summary
This gene encodes a multi-domain (WW, PDZ, FERM) containing protein. Through its interaction with other proteins (such as PSD-95), it functions as a positive regulator of dendritic spine morphogenesis and density, and is required for the maintenance of excitatory synaptic transmission. [provided by RefSeq, Jan 2010]
- PDZK10
- PDZD10
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~902.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: XL
Disease ID:MONDO:0010509
Submitter: PanelApp Australia
Inheritance Pattern: XL
Disease ID:MONDO:0010509
Submitter: G2P
Inheritance Pattern: XL
Disease ID:MONDO:0010509
Submitter: Ambry Genetics
Inheritance Pattern: XL
Disease ID:MONDO:0100148
Submitter: ClinGen
The *FRMPD4* gene encodes a neural scaffolding protein implicated in the regulation of dendritic spine density and excitatory neurotransmission. *FRMPD4* was first reported in relation to X-linked complex neurodevelopmental disorder in 2016, when a frameshift variant was reported in a multigenerational pedigree with five affected males (Hu et al., PMID: 25644381). Affected males exhibited intellectual disability, delayed or absent speech, variable epilepsy and behavioral abnormalities, while carrier females were unaffected. Two additional families were reported in 2018: two affected brothers with a deletion of exon 2 predicted to result in an in-frame 40 amino-acid deletion, and two affected half-brothers with a nonsense variant (Piard et al., PMID: 29267967). Furthermore, five truncating variants are present in DECIPHER and ClinVar in males with neurodevelopmental disorders. Note that due to technical limitations within the Gene Curation Interface, we are unable to enter and score the in-frame deletion (which is worth 1 point). While *FRMPD4* is intolerant to truncating variants (pLI 1, gnomAD v2.1.1), it is not significantly constrained for missense variants (Z = 1.95). At least 5 rare missense variants have been reported in unrelated males with intellectual disability or autism spectrum disorder (PMIDs: 23020937, 25644381, 25961944, 28263302, 29267967, DECIPHER), but in the absence of functional evidence of pathogenicity, they were not scored. This gene-disease association is also supported by protein interaction, functional alterations in non-patient cells and a mouse model (PMIDs: 19118189, 29267967). In summary, there is definitive evidence supporting the relationship between *FRMPD4* and X-linked complex neurodevelopmental disorder. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on November 2, 2022 (SOP Version 9).
Inheritance Pattern: XL
Disease ID:MONDO:0019181
Submitter: Orphanet
Inheritance Pattern: XL
Disease ID:MONDO:0010509
Submitter: Illumina
Inheritance Pattern: XL
Disease ID:MONDO:0010509
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to FRMPD4 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001368397.1. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 28 | 76 | 11 | 115 | ||
| missense | 1 | 373 | 68 | 442 | ||
| nonsense | 3 | 3 | 6 | 1 | 13 | |
| start loss | 0 | |||||
| frameshift | 3 | 8 | 1 | 12 | ||
| splice donor/acceptor (+/-2bp) | 1 | 3 | 12 | 16 | ||
| Total | 7 | 15 | 420 | 145 | 11 | 598 |
Highest pathogenic variant AF is 9.317207e-7
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001355326.1 | 17 | MANE Select | |
| Ensembl | ENSP00000502607.1 | 17 | MANE Select | |
| RefSeq | NP_001355324.1 | 18 | Standard | |
| RefSeq | NP_001355325.1 | 17 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- positive regulation of synapse structural plasticity
- postsynaptic actin cytoskeleton organization
Molecular Function
- protein binding
- phosphatidylinositol-4,5-bisphosphate binding
Cellular Component
- cytoskeleton
- postsynaptic density
- protein-containing complex
- dendritic spine
- glutamatergic synapse
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000380682
- Coding exons
- 17
- Length
- 586058
- Individuals with no LoFs
- 124979
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 1
- Defined
- 124980
- p
- 0.00000400
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.95 | 414 | 542 | 0.764 | 0.0000443 | 8659 |
| Missense (PolyPhen) | 106 | 213.89 | 0.49558 | 3430 | ||
| Synonymous | -1.61 | 263 | 232 | 1.13 | 0.0000212 | 2638 |
| Loss of Function | 5.54 | 0 | 35.7 | 0.00 | 0.00000264 | 658 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0.00021 | 0.000033 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Positive regulator of dendritic spine morphogenesis and density. Required for the maintenance of excitatory synaptic transmission. Binds phosphatidylinositol 4,5-bisphosphate. {ECO:0000269|PubMed:19118189}.;
- Disease
- DISEASE: Mental retardation, X-linked 104 (MRX104) [MIM:300983]: A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Intellectual deficiency is the only primary symptom of non-syndromic X-linked mental retardation, while syndromic mental retardation presents with associated physical, neurological and/or psychiatric manifestations. {ECO:0000269|PubMed:25644381}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0975
Intolerance Scores
- LoFtool
- 0.0193
- RVIS EVS
- -1.84
- RVIS percentile EVS
- 2.07
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.267
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |